Smith Group Asset Management LLC Invests $362,000 in DaVita Inc. $DVA

Smith Group Asset Management LLC purchased a new stake in DaVita Inc. (NYSE:DVA) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund purchased 2,355 shares of the company’s stock, valued at approximately $362,000.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Root Financial Partners LLC lifted its position in shares of DaVita by 128.0% during the first quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock worth $29,000 after purchasing an additional 105 shares in the last quarter. Caitlin John LLC bought a new position in DaVita in the 4th quarter worth approximately $34,000. Sankala Group LLC acquired a new position in DaVita during the 4th quarter worth $39,000. Canada Pension Plan Investment Board bought a new position in DaVita in the 2nd quarter valued at $43,000. Finally, Kestra Advisory Services LLC bought a new position in DaVita in the 4th quarter valued at $45,000. Institutional investors and hedge funds own 90.12% of the company’s stock.

Analyst Ratings Changes

Several brokerages have recently issued reports on DVA. TD Cowen upped their price target on DaVita from $144.00 to $201.00 and gave the company a “hold” rating in a research note on Monday, May 11th. Zacks Research lowered DaVita from a “strong-buy” rating to a “hold” rating in a research report on Monday, July 6th. UBS Group upped their target price on shares of DaVita from $235.00 to $270.00 and gave the company a “buy” rating in a research report on Friday, July 10th. Truist Financial raised their target price on shares of DaVita from $205.00 to $250.00 and gave the company a “hold” rating in a research note on Tuesday, July 14th. Finally, Barclays lifted their price target on shares of DaVita from $194.00 to $218.00 and gave the stock an “equal weight” rating in a research report on Wednesday, July 8th. Two investment analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $216.50.

DaVita Stock Performance

DVA opened at $240.59 on Thursday. The firm’s fifty day moving average is $216.12 and its two-hundred day moving average is $171.76. The firm has a market cap of $15.45 billion, a PE ratio of 22.32, a price-to-earnings-growth ratio of 0.78 and a beta of 0.88. DaVita Inc. has a twelve month low of $101.00 and a twelve month high of $244.49.

DaVita (NYSE:DVA) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.33 by $0.54. The company had revenue of $3.42 billion during the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 5.65% and a negative return on equity of 270.37%. The firm’s revenue was up 6.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $2.00 EPS. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. Equities analysts forecast that DaVita Inc. will post 15.07 EPS for the current fiscal year.

Insider Transactions at DaVita

In other DaVita news, CFO Joel Ackerman sold 51,471 shares of the business’s stock in a transaction dated Thursday, May 7th. The stock was sold at an average price of $192.10, for a total value of $9,887,579.10. Following the completion of the transaction, the chief financial officer directly owned 132,434 shares of the company’s stock, valued at approximately $25,440,571.40. The trade was a 27.99% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Kathleen Alyce Waters sold 15,405 shares of the firm’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $208.40, for a total value of $3,210,402.00. Following the sale, the insider directly owned 109,194 shares in the company, valued at approximately $22,756,029.60. This represents a 12.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 1.90% of the stock is currently owned by insiders.

DaVita Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.